Your AI-Trained Oncology Knowledge Connection!

Advances in MRD Testing for Informed CRC Treatment : Episode 8

Opinion

Video

April 1, 2024

Patient Profile: A 52-Year-Old Woman With Colorectal Cancer

Author(s):

John L. Marshall, MD,Benjamin Weinberg, MD

John L. Marshall, MD, presents the case of a 52-year-old woman with mid-rectal carcinoma, and the panel offers its initial impressions.

EP: 1.Treating Colorectal Cancer: Overview of MRD Testing and ctDNA

EP: 2.When is MRD Testing Performed in Colorectal Cancer Treatment?

EP: 3.MRD Testing Platforms in Colorectal Cancer

EP: 4.Testing for MRD in Colorectal Cancer

EP: 5.Colorectal Cancer: MRD Testing in the Community Setting

EP: 6.Practical Considerations in MRD Testing in CRC

EP: 7.Evolution of MRD Testing in Colorectal Cancer

Now Viewing

EP: 8.Patient Profile: A 52-Year-Old Woman With Colorectal Cancer

EP: 9.Colorectal Cancer: Updates from the GALAXY Arm in CIRCULATE-Japan

EP: 10.BESPOKE CRC: Study of ctDNA-Guided Therapy in Colorectal Cancer

EP: 11.Myths Surrounding Liquid Biopsy and ctDNA Testing for MRD

EP: 12.Patient Profile 2: A 35-Year-Old Man With Oligometastatic Colorectal Cancer

EP: 13.Recent Data from INTERCEPT and COSMOS-CRC-01 in Colorectal Cancer

EP: 14.Recent Data from INTERCEPT and COSMOS-CRC-01 in Colorectal Cancer: Part 2

EP: 15.CIRCULATE-NORTH AMERICA and Barriers to Enrollment

EP: 16.MRD Testing in CRC: Gaps in our Understanding and Potential Advancements

EP: 17.Trajectory of CRC Treatment Landscape

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

Latest CME

View All

Video

Addressing Unmet Needs in HER2+ Metastatic BTC

Apr 18th 2025 - Apr 19th 2026

online-activity

Video

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Apr 17th 2025 - May 23rd 2025

online-activity

Video

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

Apr 17th 2025 - May 23rd 2025

online-activity

Latest Conference Coverage

Overview of iMMagine-1 Trial: Phase 2 Registrational Study of Anitocabtagene Autoleucel for the Treatment of R/R MM

Application of Real-World Evidence in Selecting CAR T in R/R MM

Addition of Daratumumab to Lenalidomide Maintenance Boosts MRD-Negative Conversions in Myeloma Following ASCT

Apalutamide Boosts 24-Month OS in Real-World Population With Metastatic Castration-Sensitive Prostate Cancer

View More Latest Conference Coverage

Advertise

About OncLive

Editorial Board

MJH Life Sciences brands

Privacy

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

Patient Profile: A 52-Year-Old Woman With Colorectal Cancer

EP: 1.Treating Colorectal Cancer: Overview of MRD Testing and ctDNA

EP: 2.When is MRD Testing Performed in Colorectal Cancer Treatment?

EP: 3.MRD Testing Platforms in Colorectal Cancer

EP: 4.Testing for MRD in Colorectal Cancer

EP: 5.Colorectal Cancer: MRD Testing in the Community Setting

EP: 6.Practical Considerations in MRD Testing in CRC

EP: 7.Evolution of MRD Testing in Colorectal Cancer

EP: 8.Patient Profile: A 52-Year-Old Woman With Colorectal Cancer

EP: 9.Colorectal Cancer: Updates from the GALAXY Arm in CIRCULATE-Japan

EP: 10.BESPOKE CRC: Study of ctDNA-Guided Therapy in Colorectal Cancer

EP: 11.Myths Surrounding Liquid Biopsy and ctDNA Testing for MRD

EP: 12.Patient Profile 2: A 35-Year-Old Man With Oligometastatic Colorectal Cancer

EP: 13.Recent Data from INTERCEPT and COSMOS-CRC-01 in Colorectal Cancer

EP: 14.Recent Data from INTERCEPT and COSMOS-CRC-01 in Colorectal Cancer: Part 2

EP: 15.CIRCULATE-NORTH AMERICA and Barriers to Enrollment

EP: 16.MRD Testing in CRC: Gaps in our Understanding and Potential Advancements

EP: 17.Trajectory of CRC Treatment Landscape

Newsletter

Latest CME

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Updates and Innovations in Nonopioid Pain Management Strategies for Breast Cancer Patients Postsurgical Intervention

Addressing Unmet Needs in HER2+ Metastatic BTC

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Updates and Innovations in Nonopioid Pain Management Strategies for Breast Cancer Patients Postsurgical Intervention

Addressing Unmet Needs in HER2+ Metastatic BTC

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Updates and Innovations in Nonopioid Pain Management Strategies for Breast Cancer Patients Postsurgical Intervention

Latest Conference Coverage